Product News and Recalls

Don’t Let A Hospital Kill You

By Elizabeth Cohen, CNN Medical Correspondent

ATLANTA, Georgia (CNN) — Like many young men, Josh Nahum loved a thrill. That’s why he took up skydiving. But on Labor Day weekend in 2006, he had an accident while skydiving in Colorado, fracturing his femur and skull.

Josh spent six weeks in the intensive care unit. Slowly, his condition improved, and his doctors predicted that with rehabilitation, he could fully recover in a year or two.

But instead of recovering, Josh developed a bacterial infection. ...

continue reading...

Deaths linked to contaminated heparin

April 15, 2008 – Since Jan. 1, 2007, the deaths of at least eighty-one people have been linked to contaminated heparin. FDA Commissioner Andrew von Eschenbach testified before a Senate Appropriations Committee that the FDA suspected the contamination had been done deliberately, “by virtue of economic fraud.” Read More

continue reading...

Across Country, Lawsuits Link Incurable Illness to MRI Dye – Gadolinium

By Evan George
Daily Journal Staff Writer
This article appears on Page 1

HEMET – Ramon Rodriguez was always good with his hands. The ex-Marine fixed cars, stitched leather and tinkered with home improvements, despite his diabetes and a failed kidney.
But that was before his skin began turning to stone.
It started as a stiffness in his legs and pain in his joints. Then, he began tripping. When his skin toughened, his doctors were puzzled.
Last year, Rodriguez, 65, was ...

continue reading...

Investigating Ketek, Bi-Partisan Congress Focuses on Improprieties and Inadequacies of FDA and Big Pharma

The antibiotic Ketek, manufactured by Sanofi-Aventis, had been reported to cause liver failure, blurred vision and loss of consciousness in adults. Twelve adults in the United States suffered liver failure, and four of them died. Twenty-three others suffered serious liver injuries.1

The company undertook a study of Ketek in 24,000 patients to prove its safety. The trial was marred by fraud, one of the investigators on the study is now in federal prison, and another lost his medical license.1

Sanofi-Aventis first ...

continue reading...

Vioxx’s next battlefield: New Orleans

But assembling a jury for product liability trial in Katrina-ravaged city may prove difficult.

By Aaron Smith, staff writer

February 2, 2006: 1:42 PM EST

NEW YORK ( – The next big battle over Vioxx takes place in New Orleans, a city mired in its own conflicts with nature, the government and itself.

The retrial of Merck v. Plunkett is scheduled to begin Monday in New Orleans — less than two months after a trial, presided over by U.S. District Judge Eldon Fallon ...

continue reading...

Merck Wins Battle, Faces War

Matthew Herper and Robert Langreth, 11.03.05, 1:42 PM ET

Merck won a significant decision in a Vioxx lawsuit, emerging victorious on all counts in the New Jersey case of a postal worker and Vietnam veteran who said that two months of Vioxx use caused his heart attack.

“This vindicates that we acted in the right way,” said Kenneth C. Frazer, Merck’s top lawyer, on a conference call with reporters.

“This is a critical victory for Merck,” says Howard Erichson, a professor of law ...

continue reading...
Page 367 of 368 «...340350360364365366367368